You are here

  • Home
  • Archive
  • Volume 83, Issue 11
  • Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study

Citation Tools

Article menu
Systemic lupus erythematosus
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Aranow C, Allaart CF, Amoura Z, et al
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study
Annals of the Rheumatic Diseases 2024;83:1502-1512.